Medcolcanna Organics Inc.

CVE: MCCN


Canadian symbol: MCCN.V
US symbol:

Currency in CAD

Valuation Measures

Market Cap (intraday) 57.68M
Enterprise Value 37.03M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)269.10
Price/Book (mrq)1.98
Enterprise Value/Revenue 3246.22
Enterprise Value/EBITDA 6-1.27

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-52.94%
S&P500 52-Week Change 35.66%
52 Week High 30.1850
52 Week Low 30.0450
50-Day Moving Average 30.0907
200-Day Moving Average 30.0950

Share Statistics

Avg Vol (3 month) 348.33k
Avg Vol (10 day) 324.46k
Shares Outstanding 590.35M
Float 65.89M
% Held by Insiders 118.88%
% Held by Institutions 10.00%
Shares Short (Jun. 29, 2020) 432k
Short Ratio (Jun. 29, 2020) 40.39
Short % of Float (Jun. 29, 2020) 4N/A
Short % of Shares Outstanding (Jun. 29, 2020) 40.04%
Shares Short (prior month May 28, 2020) 439k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-19,689.13%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)28.54k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.77k
EBITDA -5.52M
Net Income Avi to Common (ttm)-8.09M
Diluted EPS (ttm)-0.1030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.12M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)413.42k
Total Debt/Equity (mrq)10.63
Current Ratio (mrq)2.98
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-4.96M
Levered Free Cash Flow (ttm)N/A

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
MCCN.V
Medcolcanna Organics
2 weeks ago
MCCN.V
Medcolcanna Organics
2 weeks ago
MCCN.V
Medcolcanna Organics
7 months ago
MCCN.V
Medcolcanna Organics
7 months ago
MCCN.V
Medcolcanna Organics
7 months ago
MCCN.V
Medcolcanna Organics
7 months ago
MCCN.V
Medcolcanna Organics
7 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
18.88%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Medcolcanna Organics Inc.


Medcolcanna Organics Inc. Announces Operational Update and Bridge Debenture Financing

Medcolcanna Organics Inc. Announces Operational Update and Bridge Debenture Financing

BOGOTÁ, Colombia, June 26, 2020 -- Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or “the “Company”) (TSXV: MCCN), a leading Colombian and global integrated Cannabis Company, is pleased to provide an operational update and announce that it intends to proceed with a bridge debenture financing with the principal amount of $1,000,000 (the ... Read More...
Medcolcanna Organics Inc. Announces Financial Results for the Year Ended December 31, 2019 and for the First Quarter of 2020

Medcolcanna Organics Inc. Announces Financial Results for the Year Ended December 31, 2019 and for the First Quarter of 2020

BOGOTÁ, Colombia, June 02, 2020 -- Medcolcanna Organics Inc. (“Medcolcanna” or “the “Company”) (TSXV: MCCN) announces the filing of its annual financial and operating results for the year ended December 31, 2019 and for the three months ended March 31, 2020. All dollar values in this news release and the Company’s financial disclosures ar... Read More...
Medcolcanna Announces Change to Virtual Annual General Meeting on May 21, 2020

Medcolcanna Announces Change to Virtual Annual General Meeting on May 21, 2020

BOGOTÁ, Colombia, May 19, 2020 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Thursday, May 21, 2020 at 11:00 a.m. (Bogota time) at the offic... Read More...
Medcolcanna Announces that Dona Blanca has Elected to Enter Stage 2 of the Joint Venture with Medcolcanna

Medcolcanna Announces that Dona Blanca has Elected to Enter Stage 2 of the Joint Venture with Medcolcanna

BOGOTÁ, Colombia, May 05, 2020 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that, further to its press release dated April 7, 2020, Dona Blanca Limited (“Dona Blanca”), has elected to enter stage 2 of the previou... Read More...
Medcolcanna Announces Extension of Filing Deadline of its Annual Financial Statements and MD&A and Other Corporate Matters

Medcolcanna Announces Extension of Filing Deadline of its Annual Financial Statements and MD&A and Other Corporate Matters

BOGOTÁ, Colombia, April 27, 2020 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that due to the COVID-19 pandemic, the Company intends to postpone the filing of its annual consolidated financial statements and accompanying management's... Read More...
Medcolcanna Executes Definitive Agreement for Joint Venture and extends LOI for Investment into Extraction Subsidiary

Medcolcanna Executes Definitive Agreement for Joint Venture and extends LOI for Investment into Extraction Subsidiary

BOGOTÁ, Colombia, April 07, 2020 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that, further to its press release dated February 24, 2020, through its subsidiary Medcolcanna S.A.S. it has executed a definitive joi... Read More...
Medcolcanna Signs Letters of Intent for Joint Venture and Investment into Extraction Subsidiary

Medcolcanna Signs Letters of Intent for Joint Venture and Investment into Extraction Subsidiary

BOGOTÁ, Colombia, Feb. 19, 2020 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed two (2) separate letters of intent (“LOIs”) with Dona Blanca Limited (“Dona Blanca”), an Australian based cannabis company w... Read More...
Medcolcanna Organics Inc. Announces Financial Results for the Third Quarter of 2019

Medcolcanna Organics Inc. Announces Financial Results for the Third Quarter of 2019

BOGOTA, Colombia, Dec. 02, 2019 -- Medcolcanna Organics Inc. (“Medcolcanna” or “the “Company”) (TSXV: MCCN) announces the filing of its financial and operating results on November 29, 2019 for the three and nine months ended September 30, 2019. All dollar values in this news release and the Company’s financial disclosures are in Canadian ... Read More...
Medcolcanna expands Global Leadership Team with Appointment of Chief Corporate Development Officer

Medcolcanna expands Global Leadership Team with Appointment of Chief Corporate Development Officer

BOGOTA, Colombia, Nov. 21, 2019 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”) announces the expansion of its senior leadership team with the appointment of Daniel Herrera as Chief Corporate Development Officer. Daniel will lead Medcolcanna’s corporate development function, including the global export market s... Read More...
View from the C-Suite: Felipe de la Vega, Chief Executive Officer, Medcolcanna Organics Inc., tells his company's story. Filmed on September 5, 2019

View from the C-Suite: Felipe de la Vega, Chief Executive Officer, Medcolcanna Organics Inc., tells his company’s story. Filmed on September 5, 2019

TORONTO , Oct. 17, 2019 -https://www.youtube.com/watch?v=_mukKjb3Nu0The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View... Read More...
Medcolcanna Organics Inc. Announces Financial Results for Second Quarter of 2019

Medcolcanna Organics Inc. Announces Financial Results for Second Quarter of 2019

BOGOTA, Colombia, Aug. 29, 2019 -- Medcolcanna Organics Inc. (the “Company” or “Medcolcanna”) (MCCN.V) announces the filing of its financial and operating results for the three and six months ended June 30, 2019. All dollar values in this news release and the Company’s financial disclosures are in Canadian dollars, unless otherwise stated... Read More...
Medcolcanna Signs Letter of Intent with Top Medical Center and Completes Purchase of Innovative CBD Products

Medcolcanna Signs Letter of Intent with Top Medical Center and Completes Purchase of Innovative CBD Products

BOGOTÁ, Colombia, July 25, 2019 -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed a Letter of Intent (“LOI”) with the University Medical Center Groningen (“UMCG”).“We are extremely honoured to have been chosen b... Read More...
Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical Executive

Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical Executive

BOGOTÁ, Colombia, June 11, 2019 -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce the appointment of Mr. José Joaquin Mora Hernandez to its Board of Directors as well as company advisor.“We are very pleased to welcome Mr. Mora Her... Read More...
Medcolcanna Enters Agreement to Acquire Interest in Cannabis Oil Refinery

Medcolcanna Enters Agreement to Acquire Interest in Cannabis Oil Refinery

Medcolcanna to Acquire 20% Interest in Refinery as Part of Continued Strategic Growth InitiativesBOGOTÁ, Colombia, May 30, 2019 -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is excited to announce that it has entered into a Master Agreement (the “Ag... Read More...
Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters

Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters

Medcolcanna to Acquire Innovative CBD Products B.V. as Part of Continued Strategic InitiativesBOGOTÁ, Colombia, May 23, 2019 -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a medical cannabis company operating in Colombia, is pleased to announce that its shares will begin trading on the TSX Venture Exchange (t... Read More...
Coming Soon.

Delayed data (1h)


Share this page